Clinical Trial

Imaging Features for the Risks for Recurrence After Stereotactic Radiosurgery in Brain Metastasis

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated May 14, 2024 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This trial uses multi-parametric magnetic resonance imaging (MRI) to develop and validate imaging risk score to predict radiation necrosis in participants with brain metastasis treated with radiation therapy. Diagnostic procedures, such as multi-parametric magnetic resonance imaging (MRI), may improve the ability to diagnose radiation necrosis early and help establish treatment strategies.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05868928
Lead Sponsor Asan Medical Center
Conditions Brain Metastases, Radiosurgery
Enrollment 132 participants
Start Date 2023-12-07
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2024-05-14